History Of Abnormal Pap ICD-10-CM Codes

What ICD-10 Codes are Used for History of Abnormal Pap?

A history of abnormal Pap smears is significant for monitoring and managing cervical health. Here are ten commonly used ICD-10-CM codes for History of Abnormal Pap, along with brief clinical descriptions:

Z12.4 - Encounter for screening for malignant neoplasm of cervix: Used for encounters related explicitly to cervical cancer screening, including Pap smears.

R87.612 - Abnormal cytological findings in specimens from cervix uteri: Applied when a Pap smear shows abnormal cytological findings from the cervix.

N87.1 - Mild cervical dysplasia: Utilized for cases with a history of mild cervical dysplasia, indicating slight abnormal cell changes.

N87.9 - Dysplasia of cervix uteri, unspecified: Used when there is a history of cervical dysplasia, but the severity is unspecified.

Z01.411 - Encounter for gynecological examination (general) (routine) with abnormal findings: Applied when a gynecological examination reveals abnormal findings, including abnormal Pap smear results.

N87.2 - Moderate cervical dysplasia: Utilized for cases with a history of moderate cervical dysplasia, indicating more pronounced abnormal cell changes.

N87.3 - Severe cervical dysplasia: Used for cases with severe cervical dysplasia, indicating significant abnormal cell changes.

N87.4 - Carcinoma in situ of cervix uteri: Applied when the cervix's history of carcinoma in situ (pre-cancerous cells) is documented.

N87.8 - Other dysplasia of cervix uteri: Utilized for other specified cervical dysplasia cases not categorized elsewhere.

N87.9 - Dysplasia of cervix uteri, unspecified: Used for unspecified cervical dysplasia cases in the medical history.

Which History of Abnormal Pap ICD Codes are Billable?

The billable status of the mentioned ICD-10 codes for a history of abnormal Pap smears varies:

Z12.4 - Encounter for screening for malignant neoplasm of cervix: Yes, billable. Medical expenses related to cervical cancer screening encounters, including Pap smears, are eligible for reimbursement.

R87.612 - Abnormal cytological findings in specimens from cervix uteri: Yes, billable. Costs associated with encounters where Pap smears show abnormal cytological findings from the cervix can be reimbursed.

N87.1 - Mild cervical dysplasia: Yes, billable. Medical expenses related to a history of mild cervical dysplasia are eligible for reimbursement.

N87.9 - Dysplasia of cervix uteri, unspecified: Yes, billable. Costs associated with a history of unspecified cervical dysplasia are eligible for reimbursement.

Z01.411 - Encounter for gynecological examination with abnormal findings: Yes, billable. Medical expenses for gynecological examinations with abnormal findings, including abnormal Pap smear results, can be claimed.

N87.2 - Moderate cervical dysplasia: Yes, billable. Medical expenses related to a history of moderate cervical dysplasia are eligible for reimbursement.

N87.3 - Severe cervical dysplasia: Yes, billable. Costs associated with a history of severe cervical dysplasia are eligible for reimbursement.

N87.4 - Carcinoma in situ of cervix uteri: Yes, billable. Expenses for a history of carcinoma in situ (pre-cancerous cells) of the cervix can be claimed.

N87.8 - Other dysplasia of cervix uteri: Yes, billable. Costs associated with other specified cervical dysplasia cases not categorized elsewhere can be reimbursed.

N87.9 - Dysplasia of cervix uteri, unspecified: Yes, billable. Medical expenses related to a history of unspecified cervical dysplasia are eligible for reimbursement.

Clinical Information

• An abnormal Pap smear history indicates a prior finding of abnormal cervical cell changes.
• The Pap smear (Pap test) is a screening tool for cervical cancer and pre-cancerous changes.
• Abnormal results may indicate the presence of human papillomavirus (HPV) or cellular abnormalities.
• Further evaluation, such as colposcopy and biopsy, is often required to determine the extent and nature of abnormalities.
• The management and follow-up of abnormal Pap results depend on the specific findings, including low-grade or high-grade.
• Treatment may involve watchful waiting, repeat testing, or procedures like cervical conization to remove abnormal tissue.
• Close monitoring and follow-up are crucial to promptly address any precancerous changes.
• Patient education should emphasize the importance of regular Pap testing and HPV vaccination for cervical cancer prevention.
• Healthcare practitioners may recommend more frequent screenings or continued surveillance depending on the history of abnormal Paps and treatments.
• A thorough patient history and communication are essential to tailor management and follow-up plans based on individual circumstances.

Synonyms Include

• Abnormal Pap Test Results
• Abnormal Cervical Screening
• History of Atypical Pap Smear
• Previous Abnormal Pap Results
• Cervical Screening Abnormalities